Sheng-Han Kuo, MD

Academic Appointments

  • Assistant Professor of Neurology
Sheng-Han Kuo, MD

Dr. Kuo is a Movement Disorders specialist caring for patients with cerebellar ataxia, including spinocerebellar ataxia and multiple system atrophy, and a variety of other movement disorders, such as essential tremor and Parkinson’s disease. As a physician-scientist, his research is funded by National Institutes of Health to study the role of the cerebellum in movement disorders, implicating in ataxia and tremor. He leads a multi-disciplinary research team to study the disease mechanism and to develop therapies for movement disorders via translational research and clinical trials.

Dr. Kuo is the Director for the Initiative for Columbia Ataxia and Tremor (ICAT), an interdisciplinary research group to study how the cerebellum plays a role in neurological and neurodegenerative disorders. He also serves as one of the tri-leaders for the Clinical Research Consortium for Spinocerebellar Ataxias, constituting 15 medical centers in the U.S. to study patients living with spinocerebellar ataxias. Aiming to promote research collaboration, Dr. Kuo organizes International Tremor Congress every other year, bringing researchers together to advance therapies for tremor. He was elected in 2020 as the Vice Chair for the Movement Disorders Section at American Academy of Neurology.

Dr. Kuo has received multiple scientific awards as the recognition of his contributions to neurology, including 2016 Louis V. Gerstner Jr. Scholar Merit Award, 2019 American Academy of Neurology Jon Stolk Award for Movement Disorders, and 2020 American Neurological Association Derek Denny-Brown Award.

Departmental Appointments

  • Department of Neurology
    Division of Movement Disorders

Board Certifications

  • Neurology

Areas of Expertise

  • Ataxia
  • Dystonia
  • Movement Disorders
  • Parkinson's Disease
  • Tourette's Syndrome
  • Tremor

Languages Spoken

(in addition to English)

  • Chinese

Education and Training

  • National Taiwan University School of Medicine (Taiwan)
  • Internship: Baylor College of Medicine
  • Residency: Baylor College of Medicine

Locations

  • CUMC/Neurological Institute of New York

    710 West 168th Street
    New York, NY 10032
    For new and current patient appointments, call:
    (212) 305-1303

Provider Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • Aetna [EPO, HMO, Medicare Managed Care, NYP Employee Plan, NY Signature, POS, PPO, Signature Administrators, Student Health]
  • Affinity [Essential Plan, Medicaid Managed Care]
  • AgeWell [Medicare Managed Care, Special Needs Plan]
  • Amida Care [Special Needs Plan]
  • Capital District Physician Health Plan [Capital District Physician Health Plan]
  • Cigna [EPO, Great West, HMO, POS, PPO]
  • Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
  • Empire Blue Cross Blue Shield [EPO, Medicare Managed Care, PPO]
  • Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
  • Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
  • Healthfirst [Child/Family Health Plus, Leaf (Exchange), Medicaid Managed Care, Medicare Managed Care]
  • Local 1199 [Local 1199]
  • MagnaCare [MagnaCare]
  • Multiplan [Multiplan]
  • MVP Health Care [Child/Family Health Plus, Essential Plan, HMO, Medicaid Managed Care]
  • Oxford Health Plans [Freedom, Liberty]
  • UnitedHealthcare [Columbia University Employee Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
  • VNSNY CHOICE [Medicare Managed Care, SelectHealth, Special Needs Plan]
  • WellCare [Medicaid Managed Care, Medicare Managed Care]

This provider accepts new patients

Appointment Phone Number: (212) 305-1303

Lab Locations

  • CUMC/Neurological Institute of New York

    710 West 168th Street
    New York, NY 10032

Committees / Societies / Memberships

Clinical Research Consortium for Spinocerebellar Ataxias (CRC-SCA)

Tremor Research Group

American Academy of Neurology

Movement Disorders Society

Honors and Awards

Parkinson’s Disease Foundation Lucien Côté Early Investigator Award in Clinical Genetics

Louis V. Gerstner Jr. Scholar Award

American Academy of Neurology Research Fellowship

NIH Grants

  • ARANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BHV-3241 IN SUBJECTS WITH MULTIPLE SYSTEM ATROPHY (MSA) (P&S Industry Clinical Trial)

    Oct 16 2019 - Oct 16 2024

    CEREBELLAR CIRCUITRY IN THE PATHOPHYSIOLOGY OF TREMOR (Federal Gov)

    Sep 5 2018 - Jun 30 2023

    APHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CX-8998 FOR ESSENTIAL TREMOR (P&S Industry Clinical Trial)

    Dec 4 2017 - Dec 4 2022

    DIETARY CONTRIBUTION IN CEREBELLAR ATAXIA (Federal Gov)

    Sep 15 2019 - Aug 31 2021

    THE2ND INTERNATIONAL TREMOR CONGRESS, ITC2020: FROM BENCH TO BEDSIDE TOWARDS TREMOR THERAPY DEVELOPMENT (Federal Gov)

    Apr 1 2020 - Mar 31 2021

    NEUROCRINE MTA (Private)

    Sep 7 2018 - Sep 6 2020

    ABERRANT SYNAPTIC ORGANIZATION IN TREMOR DISORDERS (Private)

    Jun 1 2018 - May 31 2020

    PATHOLOGOMICS: ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATION (Federal Gov)

    May 5 2015 - Jan 31 2020

    A PRECLINICAL STUDY OF THE EFFECTIVENESS OF D-AMINO ACID OXIDASE INHIBITOR IN ESSENTIAL TREMOR (Private)

    Oct 30 2018 - Oct 29 2019

    OPTOGENETIC INTERROGATION OF CEREBELLAR CIRCUITRY OF A NOVEL MOUSE MODEL OF ESSENTIAL TREMOR (Private)

    Jul 1 2018 - Jun 30 2019

    CLINICAL RESEARCH CONSORTIUM FOR THE STUDY OF CEREBELLAR ATAXIAS (Private)

    Apr 1 2018 - Mar 31 2019

    EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS (Federal Gov)

    Jan 1 2018 - Dec 31 2018

    A MODEL SYSTEM FOR STUDYING THE INTERACTION OF MULTIPLE PROCESSES FOR MOTOR LEARNING (Federal Gov)

    Sep 1 2013 - Aug 31 2018

    THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Federal Gov)

    Jul 1 2013 - Jun 30 2018

    THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Federal Gov)

    Jul 1 2013 - Jun 30 2018

    THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Federal Gov)

    Jul 1 2013 - Jun 30 2018

    CLINICAL RESEARCH CONSORTIUM FOR THE STUDY OF (Private)

    Jan 1 2017 - Dec 31 2017

    PARKINSON S DISEASE FOUNDATION (PDF) RESEARCH CENTER GRANT (Private)

    Jul 1 2016 - Jun 30 2017

    VALIDATION OF CHAPERONE-MEDIATED AUTOPHAGY DYSFUNCTION AND GBA ACTIVITY IN GENETIC PD IPSC-DERIVED MDA NEURONS (Private)

    Feb 26 2016 - Apr 25 2017

    PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)

    Jul 1 2000 - Jun 30 2016

    ABNORMAL CLIMBING FIBER - PURKINJE CELL SYNAPSES IN ESSENTIAL TREMOR (Private)

    Jul 1 2015 - Jun 30 2016

    MECHANISMS OF SUBSTANTIA NIGRA NEURONAL DEATH IN PARKINSON S DISEASE (Private)

    Sep 1 2012 - Aug 31 2015

    THE ROLE OF EXCLOTOXICITY IN ESSENTIAL TREMOR CEREBELLUM (Private)

    Jul 1 2014 - Jun 30 2015

    THE ROLE OF GLUCOCEREBROSIDASE AND CHAPERONE-MEDIATED AUTOPHAGY IN PARKINSON S DISEASE (Federal Gov)

    Sep 1 2013 - Aug 31 2014

    MECHANISMS OF DOPAMINE NEURON DEGENERATION (Federal Gov)

    Aug 1 2000 - Jul 31 2014

    PARKINSON S DISEASE FOUNDATION RESEARCH CENTE (Private)

    Jul 1 2000 - Jun 30 2014

    PARKINSONS DISEASE FOUNDATION RESEARCH CENTER GRANT (Private)

    Jul 1 2000 - Jun 30 2014

    GLUCOCEREBROSIDASE AND MITOCHONDRIAL AUTOPHAGY IN DOPAMINERGIC NEURONS (Private)

    Jul 1 2011 - Sep 30 2013

    MUTANT GLUCOCEREBROSIDASE CAUSES DYSFUNCTIONAL CHAPERONE MEDIATED AUTOPHAGY AND ALPHA-SYNUCLEIN ACCUMULATION IN PATIENT FIBROBLAST- DERIVED DOPAMINERGIC NEURONS (Private)

    Jun 30 2012 - Aug 31 2013

Publications